Neoadjuvant Adebrelimab in Resectable SCLC: A Randomized Trial

104 participants · First posted Jul 3, 2024

Teniposide, Cisplatin and Serplulimab for Treatment of ES-SCLC, a Randomized Controlled Study

90 participants · First posted May 13, 2026

Hippocampus Avoidance PCI vs PCI

168 participants · First posted Jan 31, 2013

DLL3xCD3 bispecific antibody (SCLC/NET)

SSTR2 targeting radionuclide drug conjugate (SCLC/NET)

Acitretin(Soriatane)

C₂₁H₂₆O₃ · Rx

A&A SMALL CHANGES HANDYPEOPLE

United States

H.LUNDBECK A/S

Meabco A/S

Denmark

Small Cell Lung Cancer Subtypes Identified, Paving Way for Personalized Treatment

Whitehawk Therapeutics Validates SEZ6 as High-Expression Target for Small Cell Lung Cancer ADC Development

Durvalumab Shifts Decades Long SOC as First FDA-Approved Immunotherapy Regimen in LS-SCLC